NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10
TD Cowen Initiates Ginkgo Bioworks(DNA.US) With Buy Rating, Announces Target Price $10
Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI Advancements and Market Expansion
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Bioworks Executive Sells Over $1,900 in Stock
Is Ginkgo Bioworks Holdings, Inc. (DNA) A Good High Risk High Reward Growth Stock To Buy?
Express News | Ginkgo Bioworks Awarded $118M U.S. Government HHS Contract
Ginkgo Regains Compliance With NYSE Minimum Bid Price Requirement
NYSE to Commence Delisting Proceedings With Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Stocks Hitting All-time Highs: JPM, KO, LMT, UNH, and More
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $7
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
Ginkgo Bioworks Holdings Analyst Ratings
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $7
Ginkgo Bioworks Holdings: Sell Rating Affirmed With Revised Valuation and Price Target